Klisyri

Chemical Nametirbanibulin
Dosage FormOintment (topical; 1%)
Drug ClassInhibitors
SystemSkin
CompanyAlmirall, LLC
Approval Year2020

Indication

  • For the topical treatment of actinic keratosis of the face or scalp
Last updated on 12/18/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Klisyri (tirbanibulin) Prescribing Information. 2020Almirall, LLC Exton, PA